查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1552614

奈米膠囊市場規模、佔有率、趨勢分析報告：按應用、治療領域、地區、細分市場預測，2024-2030

Nanocapsules Market Size, Share & Trends Analysis Report By Application (Healthcare, Food & Nutraceuticals, Cosmetics), By Therapeutic Area (Oncology, Pain Management, Endocrinology), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

奈米膠囊市場成長與趨勢：

根據Grand View Research, Inc.最新報告顯示，預計到2030年全球奈米膠囊市場規模將達48.9億美元。

預計2024年至2030年複合年成長率為5.4%。奈米膠囊透過標靶遞送來遞送生物活性分子，並在醫療保健、基因工程、食品科學和農業、化妝品、農業化學品和清潔產品等各個行業中得到應用。這些產品在各個行業的廣泛使用為新的和改進的治療方法和解決方案的開發和商業化帶來了豐厚的機會。

奈米膠囊的生命科學應用依賴於其實現奈米藥物載體受控且有效釋放到目標區域的能力。奈米膠囊因其高效的藥物靶向性而在醫療保健領域越來越受歡迎。奈米膠囊具有分散穩定性和快速的生理反應，其自燃和氧化特性使其越來越被接受為診斷和治療醫學疾病的有效藥物。人們發現奈米技術在醫學中的應用具有重要的治療益處，特別是在腫瘤學中，從而導致了一個新領域的出現，即奈米腫瘤學，其中涉及奈米膠囊的化療或診斷特性。

奈米技術的使用已擴展到各個科學領域，也應用於化妝品和農業。化妝品利用聚合物奈米顆粒（奈米球和奈米膠囊）進行有效的局部給藥。同時，奈米技術被認為是現代農業最重要的工具之一，預計在不久的將來成為經濟強勁成長的驅動力。然而，儘管奈米技術具有許多潛在好處，但目前在農業中的應用仍很薄弱，尚未實現巨大的市場潛力。然而，最近的研究表明，奈米膠囊及其各自的產品受到了人們的偏好，並且具有明顯優勢的奈米技術產品的日益商業化將推動消費者接受更精細的應用，這很有可能實現。

奈米膠囊市場報告亮點

  • 腫瘤學中的奈米膠​​囊旨在靶向腫瘤部位，然後根據不斷變化的條件排放其內容物。
  • 奈米膠囊藥物遞送在疼痛管理和內分泌領域正在快速發展，具有很高的商業化潛力。
  • 醫療保健佔據市場主導地位，到 2023 年將佔據 63.3% 的佔有率，預計在預測期內將以最快的複合年成長率成長。
  • 北美和歐洲國家總合佔60%的市場佔有率。這是由於已開發國家增加了研發和投資活動的貢獻，重點是開發新的、高效的改進治療方法，包括使用奈米膠囊。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章奈米膠囊市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 奈米膠囊市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 奈米膠囊市場：依應用估算與趨勢分析

  • 細分儀表板
  • 奈米膠囊市場：2023 年和 2030 年應用變化分析
  • 衛生保健
  • 食品/食品補充品
  • 化妝品
  • 其他

第5章奈米膠囊市場：按治療領域估計和趨勢分析

  • 細分儀表板
  • 奈米膠囊市場：2023 年和 2030 年治療領域變化分析
  • 腫瘤學
  • 疼痛管理
  • 內分泌學
  • 其他

第6章奈米膠囊市場：區域估計和趨勢分析

  • 2023 年及 2030 年奈米膠囊市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • BioDelivery Sciences
    • Camurus
    • Carlina Technologies
    • Cerulean Pharma Inc.
    • Nano Green Sciences, Inc.
    • NanoNutra
    • NanoSphere Health Science
    • Eos Biosciences, Inc.
    • PolyMicrospheres
    • GAT Food Essentials
簡介目錄
Product Code: GVR-1-68038-748-3

Nanocapsules Market Growth & Trends:

The global nanocapsules market size is expected to reach a value of USD 4.89 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.4% from 2024 to 2030. Nanocapsules deliver bioactive molecules by targeted delivery and find application in various industries such as healthcare, genetic engineering, food science and agriculture, cosmetics, agrochemicals, cleansing products, among others. The wide usage of these products across several industries promises lucrative opportunities for the development and commercialization of novel and improved therapies and solutions.

Nanocapsules' life science applications rely on the ability to achieve controlled and effective release of nano-sized drug carriers to targeted zones. Nanocapsules in the field of healthcare is gaining popularity for its efficient drug targeting. It offers dispersion stability and the quick physiological response and the pyrophoric and oxidation properties are responsible for increased acceptance as an effective agent to diagnose and cure medical disorders. The application of nanotechnology in medicine has been realized to contain important therapeutic benefits, especially in oncology, resulting in the emergence of nano-oncology, a new field involving the chemotherapeutic or diagnostic properties of nanocapsules.

The use of nanotechnology has stretched across various streams of science and has found applications in the field of cosmetics and agriculture. Cosmetic products utilize polymeric nanoparticles (nanospheres and nanocapsules) for efficient topical administration. On the other hand, nanotechnology is recognized to be one of the most important tools in modern agriculture and is anticipated to become a driving factor for strong economic growth in the near future. However, despite the numerous potential advantages of nanotechnology, agricultural applications are scarce in the current scenario and yet to achieve significant market potential. However, recent studies have demonstrated a positive preference for nanocapsules and their respective products and the increasing commercialization of nanotech products with clear benefits will likely drive consumer acceptance of more sensitive applications.

Nanocapsules Market Report Highlights:

  • Nanocapsules in oncology are engineered to target tumor sites followed by discharge of contents upon a change in conditions.
  • Rapid development in the fields of pain management and endocrinology with respect to nanocapsule drug delivery is in pipeline and has a high probability of commercialization.
  • Healthcare dominated the market and accounted for a share of 63.3% in 2023 and is expected to grow at the fastest CAGR over the forecast period
  • North America and Europe accounted for a collective market share of 60%. this is attributed to the contribution of highly developed countries in increasing R&D and investing activities focusing on the development of novel and highly effective improved therapies involving the use of nanocapsule.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Nanocapsules Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Nanocapsules Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Nanocapsules Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Nanocapsules Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Healthcare
    • 4.3.1. Healthcare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Food & Nutraceuticals
    • 4.4.1. Food & Nutraceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Cosmetics
    • 4.5.1. Cosmetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Nanocapsules Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Nanocapsules Market: Therapeutic Area Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Oncology
    • 5.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Pain Management
    • 5.4.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Endocrinology
    • 5.5.1. Endocrinology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Nanocapsules Market: Regional Estimates & Trend Analysis

  • 6.1. Nanocapsules Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Sweden Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Thailand Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Nanocapsules Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. BioDelivery Sciences
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Camurus
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Carlina Technologies
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Cerulean Pharma Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Nano Green Sciences, Inc.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. NanoNutra
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. NanoSphere Health Science
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Eos Biosciences, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. PolyMicrospheres
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. GAT Food Essentials
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives